Public Company News

XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched

SAO PAULO, May 24, 2024 /PRNewswire/ -- In a significant move to strengthen its foothold in the Latin American market,XCMG Machinery ("XCMG", SHE:000425) has ramped up its operations, marking the 50th anniversary of the establishment of diplomatic relations betweenChina and Brazil. The company's ...

2024-05-24 19:27 5359

CNFinance to Hold Annual General Meeting on June 7, 2024

GUANGZHOU, China, May 24, 2024 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it will hold its annual general meeting of shareholders (the "AGM") at 44/F, Tower G, No. 16 Zhujiang Do...

2024-05-24 18:00 5057

Atour Unveils Sustainability Records in 2023 With Milestone ESG Report

SHANGHAI, May 24, 2024 /PRNewswire/ -- May 23, Atour Lifestyle Holdings Limited (NASDAQ: ATAT), a leading hospitality and lifestyle company inChina, has released its inaugural Environmental, Social, and Governance (ESG) report for 2023. The report underscores the company's sustainability efforts...

2024-05-24 18:00 5345

36Kr Hosts "AI Partner • Advanced Productivity" Conference

BEIJING, May 24, 2024 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today hosted its "AI Partner • Advanced Productivity" Conference inBeijing, exploring AI technology...

2024-05-24 18:00 6730

New Oriental Extends Share Repurchase Program

BEIJING, May 24, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that its board of directors has authorized the Company to extend its share repurch...

2024-05-24 17:00 2819

Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

* Anittumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA. * Sunvozertinib could effectively clear EGFR exon20ins in plasma ctDNA, confirming its direct effect on EGFR pathway. * The resistance to sunvozertinib could be thro...

2024-05-24 16:32 3032

Omnicom Media Group Expands Its Partnership with Lumen, Further Advancing Attention-Based Planning Capabilities Across Its Regions

LONDON, May 24, 2024 /PRNewswire/ -- Omnicom Media Group (OMG) the media services division of leading global marketing and corporate communications holding company Omnicom Group Inc (NYSE: OMC) is expanding its market intelligence relationship with leading attention research company Lumen to now ...

2024-05-24 15:00 4166

NEC Thailand Partners with AIRA Factoring to Enhance Digital Supply Chain Finance Services

BANGKOK, May 24, 2024 /PRNewswire/ -- NEC Corporation (Thailand) Limited (NEC Thailand) has announced a strategic partnership with AIRA Factoring Public Company Limited (AIRA Factoring) to elevate digital supply chain finance solutions through innovative technology and collaborative efforts. This...

2024-05-24 14:52 3997

CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website

* CS5001 is the first known ROR1 antibody-drug conjugate (ADC) to demonstrate clinical anti-tumor activity in both solid tumors and lymphomas, and among the top two globally in clinical development. * First-in-human study data show that CS5001 is well tolerated with promising anti-tumor activ...

2024-05-24 13:00 4585

ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates

SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations a...

2024-05-24 09:15 3345

Antengene To Present One Oral and Four Abstracts at ASCO 2024

* Oral Presentation:a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1 antibody in patients with cervical cancer * Three Poster presentations: Phase I/II studies of ATG-031 (anti-CD24 monoclonal antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), and selinexor(XPO1 Inh...

2024-05-24 08:30 4127

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharm...

2024-05-24 08:00 3206

CNOOC Limited Subsidiaries Signed EPCCs with MIREME and ENH

HONG KONG, May 24, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces its wholly owned subsidiaries have entered into petroleum exploration and production concession contracts (EPCCs) with the Ministry of Mineral Resources ...

2024-05-24 08:00 5324

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 24, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharm...

2024-05-24 08:00 3747

ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE

Operation aims to strengthen the Company's financial position and maintain growth strategy SAO PAULO, May 24, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3), a leading oncology company headquartered inLatin America, has announced that the enterprise has approved a capital increase ofR$ 1.5 bil...

2024-05-24 06:41 3740

Infobird Co., Ltd Receives Notification from Nasdaq for Failure to Timely File Form 20-F

HONG KONG, May 23, 2024 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions inChina, today reports that as of May 16, 2024, it is delinquent in filing its annual report on Form 20-F for the fi...

2024-05-24 06:00 4802

SEMIFIVE Signs MOU with Atron Technologies to Collaborate on Semiconductor Design

Expected to expand global business in the Chinese market SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- SEMIFIVE, a leading design solution provider and pioneer of platform-based custom silicon solutions, has announced its agreement of MOU withChina-based Atron Technologies, on May 23, 2024. T...

2024-05-24 06:00 4728

Emeren Announces First Quarter 2024 Financial Results

STAMFORD, Conn., May 23, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com ) (NYSE: SOL), a leading global solar project developer, owner, and operator, today announced its unaudited financial results for the first quarter endedMarch 31, 202...

2024-05-24 04:05 4662

uCloudlink Introduces New GlocalMe® Life Series at VivaTech 2024 With Three New One-for-All Mobile Devices That Redefine The Way Digital Consumers Connect And Communicate Wherever They Are In The World

PARIS, May 23, 2024 /PRNewswire/ -- GlocalMe®, the digital lifestyle brand under uCloudLink Group Inc. ("uCloudlink") (NASDAQ: UCL), today introduced three new products at VivaTech 2024. The GlocalMe Life KeyTracker, RoamPlug and Unicord are the latest products under the new GlocalMe Life product...

2024-05-23 22:50 5729

Computex 2024: DeCloak Intelligences Showcases DeCloakVision Multi-Modal AI Privacy-Enhanced Monitoring System Offering the Optimal Balance between Public Safety & Personal Privacy

LAS VEGAS and TAIPEI, May 23, 2024 /PRNewswire/ -- DeCloak Intelligences, a subsidiary of Etron Technology (TPEx: 5351), has won the CES Innovation Award for two consecutive years and its privacy system has also been recognized with the Excellent Manufacturer Innovation Product Award inTaiwan. De...

2024-05-23 22:00 4171